Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02368951 |
| Title | Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| San Francisco | California | 94115 | United States | Details | ||
| Santa Monica | California | 90404-1200 | United States | Details | ||
| New Haven | Connecticut | 06520 | United States | Details | ||
| Chicago | Illinois | 60611 | United States | Details | ||
| Baltimore | Maryland | 21231 | United States | Details | ||
| St Louis | Missouri | 63110 | United States | Details | ||
| New York | New York | 10016 | United States | Details | ||
| Nashville | Tennessee | 37232 | United States | Details | ||
| Houston | Texas | 77030 | United States | Details | ||
| Seattle | Washington | 98109-1023 | United States | Details | ||
| Singapore | 169610 | Singapore | Details | |||
| Seoul | 03080 | South Korea | Details | |||
| Seoul | 138-736 | South Korea | Details |